These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21609376)

  • 1. Bilirubin levels predict malignancy in patients with obstructive jaundice.
    Garcea G; Ngu W; Neal CP; Dennison AR; Berry DP
    HPB (Oxford); 2011 Jun; 13(6):426-30. PubMed ID: 21609376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total bilirubin is a good discriminator between benign and malignant biliary strictures.
    Vasilieva L; Alexopoulou A; Papadhimitriou SI; Romanos A; Xynopoulos D; Dourakis SP
    HPB (Oxford); 2012 Jan; 14(1):71. PubMed ID: 22151455
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjusting CA19-9 values to predict malignancy in obstructive jaundice: influence of bilirubin and C-reactive protein.
    La Greca G; Sofia M; Lombardo R; Latteri S; Ricotta A; Puleo S; Russello D
    World J Gastroenterol; 2012 Aug; 18(31):4150-5. PubMed ID: 22919247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can red cell distribution width help to discriminate benign from malignant biliary obstruction? A retrospective single center analysis.
    Beyazit Y; Kekilli M; Ibis M; Kurt M; Sayilir A; Onal IK; Purnak T; Oztas E; Tas A; Yesil Y; Arhan M
    Hepatogastroenterology; 2012; 59(117):1469-73. PubMed ID: 22683963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease.
    Kim MS; Jeon TJ; Park JY; Choi J; Shin WC; Park SE; Seo JY; Kim YM
    Korean J Gastroenterol; 2017 Aug; 70(2):96-102. PubMed ID: 28830135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of percutaneous biliary drainage on serum levels of tumor markers in patients with obstructive jaundice.
    Koroglu M; Koroglu BK; Akhan O; Coskun HS; Yildizz H; Yesildag A; Oyar O
    Hepatogastroenterology; 2006; 53(70):491-6. PubMed ID: 16995447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of biliary strictures to determine the predictors of malignancy.
    Bain VG; Abraham N; Jhangri GS; Alexander TW; Henning RC; Hoskinson ME; Maguire CG; Lalor EA; Sadowski DC
    Can J Gastroenterol; 2000 May; 14(5):397-402. PubMed ID: 10851279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Magnetic Resonance Cholangiopancreatography in the Evaluation of Obstructive Jaundice.
    Karki S; Phuyal A; Paudel RC; Bhandari A; Dahal MR
    Kathmandu Univ Med J (KUMJ); 2021 Jan.-Mar; 19(73):35-40. PubMed ID: 34812155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and radiological predictors of malignant biliary strictures.
    Al-Mofleh IA; Aljebreen AM; Al-Amri SM; Al-Rashed RS; Al-Faleh FZ; Al-Freihi HM; Abdo AA; Isnani AC
    World J Gastroenterol; 2004 May; 10(10):1504-7. PubMed ID: 15133862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
    Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
    Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors in the differential diagnosis of benign and malignant causes in patients undergoing endoscopic retrograde cholangiopancreatography for extrahepatic cholestasis.
    Yildirim O; Erdogan MA
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11457-11463. PubMed ID: 38095393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin.
    Boldorini R; Paganotti A; Andorno S; Orlando S; Mercalli F; Orsello M; Ballarè M; Magnani C; Sartori M
    J Clin Pathol; 2015 Apr; 68(4):283-7. PubMed ID: 25681513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fate of patients with obstructive jaundice.
    Björnsson E; Gustafsson J; Borkman J; Kilander A
    J Hosp Med; 2008 Mar; 3(2):117-23. PubMed ID: 18438808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of magnetic resonance cholangiopancreatography (MRCP) in obstructive jaundice.
    Munir K; Bari V; Yaqoob J; Khan DB; Usman MU
    J Pak Med Assoc; 2004 Mar; 54(3):128-32. PubMed ID: 15129871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET/CT in differentiating malignant from benign origins of obstructive jaundice.
    Wang SB; Wu HB; Wang QS; Zhou WL; Tian Y; Ji YH; Lv L
    Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):516-22. PubMed ID: 26459728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of preoperative biliary drainage on liver function changes in patients with malignant obstructive jaundice in the low bile duct before and after pancreaticoduodenectomy].
    Chen D; Liang LJ; Peng BG; Zhou Q; Li SQ; Tang D; Huang L; Huang JF
    Ai Zheng; 2008 Jan; 27(1):78-82. PubMed ID: 18184470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum alkaline phosphatase, aminotransferases, gamma-glutamyl transferase, leucine aminopeptidase, and bilirubin in the distinction between benign and malignant diseases causing jaundice and cholestasis: results from a prospective study.
    Pasanen P; Pikkarainen P; Alhava E; Partanen K; Penttilä I
    Scand J Clin Lab Invest; 1993 Feb; 53(1):35-9. PubMed ID: 8095735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy.
    Leelawat K; Sakchinabut S; Narong S; Wannaprasert J
    BMC Gastroenterol; 2009 Apr; 9():30. PubMed ID: 19405942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scoring system for the prediction of choledocholithiasis: a prospective cohort study.
    Al-Jiffry BO; Khayat S; Abdeen E; Hussain T; Yassin M
    Ann Saudi Med; 2016; 36(1):57-63. PubMed ID: 26922689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.